Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III)-Reference-Cited by-同舟云学术

Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III)

Published:1998-07 Issue:1 Volume:136 Page:115-124
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Herrington David M.,Fong Josephine,Sempos Christopher T.,Black Dennis M.,Schrott Helmut G.,Rautaharju Pentti,Bachorik Paul S.,Blumenthal Roger,Khan Steven,Wenger Nanette K.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference49 articles.

1. Hormone therapy to prevent disease and prolong life in postmenopausal women;Grady;Ann Intern Med,1992

2. The epidemiology of cardiovascular disease in postmenopausal women;Bush;Ann NY Acad Sci,1990

3. The primary prevention of coronary heart disease in women;Rich-Edwards;N Engl J Med,1995

4. Noncontraceptive estrogen use and risk of cardiovascular disease: an overview and critique of the literature;Bush,1970

5. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence;Stampfer;Prev Med,1991

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on hormone therapy in postmenopausal women: mini-review for the basic scientist;American Journal of Physiology-Heart and Circulatory Physiology;2017-11-01

2. Long-term hormone therapy for perimenopausal and postmenopausal women;Cochrane Database of Systematic Reviews;2017-01-17

3. Longitudinal effects of menopausal hormone treatments on platelet characteristics and cell-derived microvesicles;Platelets;2015-04-09

4. Long term hormone therapy for perimenopausal and postmenopausal women;Cochrane Database of Systematic Reviews;2012-07-11

5. Observational Epidemiology Within Randomized Clinical Trials: Getting a Lot for (Almost) Nothing;Progress in Cardiovascular Diseases;2012-01